Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study.

JMIR Diabetes
Richard MilaniLawrence Blonde

Abstract

Diabetes is present in 10.5% of the US population and accounts for 14.3% of all office-based physician visits made by adults. Despite this established office-based approach, the disease and its adverse outcomes including glycemic control and clinical events tend to worsen over time. Available home technology now provides accurate, reliable data that can be transmitted directly to the electronic medical record. This study aims to evaluate the impact of a virtual, home-based diabetes management program on clinical measures of diabetes control compared to usual care. We evaluated glycemic control and other diabetes-related measures after 1 year in 763 patients with type 2 diabetes enrolled into a home-based digital medicine diabetes program and compared them to 794 patients matched for age, sex, race, BMI, hemoglobin A1c (HbA1c), creatinine, estimated glomerular filtration rate, and insulin use in a usual care group after 1 year. Digital medicine patients completed questionnaires online, received medication management and lifestyle recommendations from a clinical pharmacist or advanced practice provider and a health coach, and were asked to submit blood glucose readings using a commercially available Bluetooth-enabled glucose mete...Continue Reading

References

Jan 31, 2002·Health Affairs·E H WagnerA Bonomi
Oct 26, 2002·BMJ : British Medical Journal·John E Wennberg
Feb 18, 2003·Archives of Internal Medicine·Gerard F Anderson
Mar 1, 2005·Diabetes Care·William H PolonskyRichard A Jackson
May 14, 2008·Annals of Family Medicine·Lawrence FisherWilliam H Polonsky
Mar 19, 2011·BMJ : British Medical Journal·John E Wennberg
Jun 22, 2012·The New England Journal of Medicine·David S JonesJeremy A Greene
Apr 26, 2013·The New England Journal of Medicine·Mohammed K AliEdward W Gregg
Sep 24, 2013·Health Policy·Ashley N CoralloTherese A Stukel
Dec 3, 2014·The American Journal of Medicine·Richard V Milani, Carl J Lavie
Mar 4, 2015·Health Affairs·Jessica GreeneCarmen D Parrotta
Dec 24, 2015·Diabetes Care·UNKNOWN American Diabetes Association
Jan 17, 2016·Progress in Cardiovascular Diseases·Richard V MilaniCarl J Lavie
Sep 4, 2016·The American Journal of Medicine·Richard V MilaniHector O Ventura
Oct 4, 2016·Progress in Cardiovascular Diseases·Richard V MilaniHector O Ventura
Dec 28, 2016·JAMA : the Journal of the American Medical Association·Joseph L DielemanChristopher J L Murray
Feb 6, 2017·Patient Education and Counseling·Rebecca M SacksCarmen D Parrotta
Apr 1, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Zhou ZhouRaafat Seifeldin
Jun 2, 2017·Current Diabetes Reports·Sherita Hill GoldenFelicia Hill-Briggs
Jun 25, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ginger CarlsSteven V Edelman
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Mar 24, 2018·Diabetes Care·UNKNOWN American Diabetes Association
Dec 19, 2018·Diabetes Care·UNKNOWN American Diabetes Association
Dec 19, 2018·Diabetes Care·UNKNOWN American Diabetes Association
Feb 2, 2019·Clinical Diabetes : a Publication of the American Diabetes Association·UNKNOWN American Diabetes Association
Apr 16, 2019·JAMA : the Journal of the American Medical Association·Edward W GreggStephen R Benoit
Jun 23, 2019·American Journal of Preventive Medicine·Timothy W LevengoodUNKNOWN Community Preventive Services Task Force
Jul 24, 2020·Clinical Diabetes : a Publication of the American Diabetes Association·Iakovos AvramidisGeorgios Pilianidis
Aug 28, 2020·The New England Journal of Medicine·Elizabeth A McGlynn
Apr 20, 2021·Current Opinion in Cardiology·Richard V MilaniHector O Ventura

❮ Previous
Next ❯

Software Mentioned

SAS
MyChart

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
Russell L RothmanMichael P Pignone
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Srinivas PanjaKathleen M Colleran
© 2021 Meta ULC. All rights reserved